-
1دورية أكاديمية
المؤلفون: Ben-Aharon, I, van Laarhoven, HWM, Fontana, E, Obermannova, R, Nilsson, M, Lordick, F
المصدر: Cancer discovery. 13(3):538-551
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
المؤلفون: Ben-Aharon, I., Lordick, F.
المصدر: ESMO Gastrointestinal Oncology ; volume 1, page 1-2 ; ISSN 2949-8198
الإتاحة: https://doi.org/10.1016/j.esmogo.2023.10.001Test
https://api.elsevier.com/content/article/PII:S2949819823000146?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2949819823000146?httpAccept=text/plainTest -
3دورية أكاديمية
المؤلفون: Fontana, E., Ben-Aharon, I.
المصدر: ESMO Gastrointestinal Oncology ; volume 1, page 40-42 ; ISSN 2949-8198
الإتاحة: https://doi.org/10.1016/j.esmogo.2023.08.005Test
https://api.elsevier.com/content/article/PII:S2949819823000067?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2949819823000067?httpAccept=text/plainTest -
4دورية أكاديمية
المؤلفون: Halpern N, Grinshpun A, Boursi B, Golan T, Margalit O, Aderka D, Friedman E, Laitman Y, Hubert A, Kadouri L, Hamburger T, Barnes-Kedar I, Levi Z, Ben-Aharon I, Brenner B, Goldberg Y, Peretz T, Shacham-Shmueli E
المصدر: OncoTargets and Therapy, Vol Volume 13, Pp 11637-11644 (2020)
مصطلحات موضوعية: gastric cancer, brca1, brca2, dna damaging agents, parp inhibitors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Koessler, T., Alsina, M., Arnold, D., Ben-Aharon, I., Collienne, M., Lutz, M.P., Neuzillet, C., Obermannova, R., Peeters, M., Sclafani, F., Smyth, E., Valle, J.W., Wagner, A.D., Wyrwicz, L., Fontana, E., Moehler, M.
المساهمون: Hôpitaux universitaires de Genève = University Hospitals of Geneva (HUG), Université de Genève = University of Geneva (UNIGE), Vall d'Hebron Institute of Oncology Barcelone (VHIO), Vall d'Hebron University Hospital Barcelona, Rappaport faculty of Medicine, Technion - Israel Institute of Technology Haifa, European Organisation for Research and Treatment of Cancer Bruxelles (EORTC), European Cancer Organisation Bruxelles (ECCO), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Curie Paris, Masaryk Memorial Cancer Institute (MMCI), Masaryk University Brno (MUNI), Antwerp University Hospital Edegem (UZA), Institut Jules Bordet Bruxelles, Faculté de Médecine Bruxelles (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Cambridge University Hospitals - NHS (CUH), University of Cambridge UK (CAM), University of Manchester Manchester, The Christie NHS Foundation Trust Manchester, Royaume-Uni, Centre Hospitalier Universitaire Vaudois = Lausanne University Hospital Lausanne (CHUV), Université de Lausanne = University of Lausanne (UNIL), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), Sarah Cannon Research Institute Nashville, Tennessee, Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU), Bristol-Myers Squibb, BMS, Eli Lilly and Company, Merck, Roche, Boehringer Ingelheim, Servier, Krebsforschung Schweiz, This work was supported by a donation from the Swiss Cancer Research Foundation from Switzerland. MC was supported by a grant by EORTC Cancer Research Fund (ECRF) and the Gastrointestinal Tract Cancer Group. TK discloses consulting or advisory role for Merck Sharp & Dohme (MSD), Bristol Myers Squibb (BMS), Lilly, Roche, Boehringer Ingelheim, and Servier. MA discloses consulting or advisory role for MSD, BMS, Lilly, and Servier. RO discloses consulting or advisory role for BMS, Merck, MSD, and Servier, Speakers Bureau for BMS, Eli Lilly, Merck, Roche, and Servier, and received Travel Grants from BMS, Merck and Servier. JWV discloses consulting or advisory role for Agios, AstraZeneca, Delcath Systems, Keocyt, Genoscience Pharma, Incyte, Ipsen, Merck, Mundipharma EDO, Novartis, PCI Biotech, Pfizer, Pieris Pharmaceuticals, QED, and Wren Laboratories, Speakers Bureau for Imaging Equipment Limited, Ipsen, Novartis, Nucana, and received Travel Grants from Celgene and Nucana. All other authors have declared no conflicts of interest., This work was supported by a donation from the Swiss Cancer Research Foundation from Switzerland. MC was supported by a grant by EORTC Cancer Research Fund (ECRF) and the Gastrointestinal Tract Cancer Group.
المصدر: ISSN: 2059-7029 ; ESMO Open ; https://hal.science/hal-03642598Test ; ESMO Open, 2022, 7 (2), pp.100392. ⟨10.1016/j.esmoop.2022.100392⟩.
مصطلحات موضوعية: colorectal cancer, neuroendocrine tumours, oesophagus cancer, pancreatic cancer, stomach cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35180656; hal-03642598; https://hal.science/hal-03642598Test; https://hal.science/hal-03642598/documentTest; https://hal.science/hal-03642598/file/main.pdfTest; PUBMED: 35180656
الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100392Test
https://hal.science/hal-03642598Test
https://hal.science/hal-03642598/documentTest
https://hal.science/hal-03642598/file/main.pdfTest -
6دورية أكاديمية
المؤلفون: Kossler, Thibaud, Alsina, M, Arnold, D, Ben-Aharon, I, Collienne, M, Lutz, M P, Neuzillet, C, Obermannova, R, Peeters, M, Sclafani, F, Smyth, E, Valle, J W, Wagner, A D, Wyrwicz, L, Fontana, E, Moehler, M
المصدر: ISSN: 2059-7029 ; ESMO open, vol. 7, no. 2 (2022) 100392.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Colorectal cancer, Neuroendocrine tumours, Oesophagus cancer, Pancreatic cancer, Stomach cancer, Gastrointestinal Neoplasms / drug therapy, Humans, Immunotherapy, Medical Oncology
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35180656; https://archive-ouverte.unige.ch/unige:169039Test; unige:169039
-
7دورية أكاديمية
المؤلفون: Holland, R., Miron, K., Goshen-Lago, T., Gordon, N., Zer, A., Ben-Aharon, I.
المصدر: Annals of Oncology ; volume 33, page S1309 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.1756Test
https://api.elsevier.com/content/article/PII:S0923753422036079?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422036079?httpAccept=text/plainTest -
8دورية أكاديمية
المؤلفون: Shitara, K., Ben-Aharon, I., Rojas, C., Acosta Eyzaguirre, D.A., Hubert, A., Araya Moya, H., Cohen, D., Bai, L-Y., Ghiringhelli, F., Wyrwicz, L., Janjigian, Y.Y., Tabernero, J., Van Cutsem, E., Qin, S., Xu, J., Wang, A., Miller, M.G., Shih, C-S., Bhagia, P., Yanez Weber, P.E.
المصدر: Annals of Oncology ; volume 33, page S1108 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.1341Test
https://api.elsevier.com/content/article/PII:S0923753422031921?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422031921?httpAccept=text/plainTest -
9دورية أكاديمية
المؤلفون: Zer, A., Goshen-Lago, T.G., Ben-Aharon, I., Passhak, M.
المصدر: Annals of Oncology ; volume 33, page S1278 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.1702Test
https://api.elsevier.com/content/article/PII:S0923753422035530?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422035530?httpAccept=text/plainTest -
10دورية أكاديمية
المؤلفون: Ben-Aharon, I., Turgeman, I., Nemzov, S., Karov, K., Bagon, S., Silman-Cohen, H., Israeli, H., Goshen - Lago, T.G.
المصدر: Annals of Oncology ; volume 32, page S1102 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.831Test
https://api.elsevier.com/content/article/PII:S092375342103060X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342103060X?httpAccept=text/plainTest